4//SEC Filing
Lavelle Erin M. 4
Accession 0001209191-21-032400
CIK 0001404644other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:37 PM ET
Size
5.6 KB
Accession
0001209191-21-032400
Insider Transaction Report
Form 4
Lavelle Erin M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-05-11+25,000→ 25,000 totalExercise: $11.40Exp: 2031-05-10→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the total shares monthly beginning June 11, 2021 until the option is fully vested on May 11, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001813250
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:37 PM ET
- Size
- 5.6 KB